Personalized stem cell shot tested to fight ALS
NCT ID NCT06910384
Summary
This study tested whether a treatment made from a patient's own bone marrow stem cells (called STR04) could help control Amyotrophic Lateral Sclerosis (ALS). The goal was to see if four intravenous doses could slow the decline in muscle function and breathing. The trial was terminated early and only enrolled one participant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Neuromuscular Research Institute
Austin, Texas, 78759, United States
Conditions
Explore the condition pages connected to this study.